tiprankstipranks
The Fly

Halozyme raises FY24 non-GAAP EPS view to $3.65-$4.05 from $3.55-$3.90

Halozyme raises FY24 non-GAAP EPS view to $3.65-$4.05 from $3.55-$3.90

Consensus for FY24 EPS is $3.73. Raises FY24 revenue view to $935M-$1.02B from $915M-$985M, consensus $947.33M.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Questions or Comments about the article? Write to editor@tipranks.com